ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,135,000 | -40.2% | 35,300 | -44.8% | 0.00% | -25.0% |
| Q2 2022 | $1,899,000 | +1.4% | 64,000 | -3.9% | 0.00% | +33.3% |
| Q1 2022 | $1,872,000 | -35.8% | 66,600 | +5.2% | 0.00% | -40.0% |
| Q4 2021 | $2,917,000 | +0.2% | 63,300 | -28.6% | 0.01% | 0.0% |
| Q3 2021 | $2,911,000 | -6.3% | 88,700 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $3,108,000 | -0.2% | 88,700 | +2.9% | 0.01% | 0.0% |
| Q1 2021 | $3,114,000 | +64.2% | 86,186 | +32.0% | 0.01% | +66.7% |
| Q4 2020 | $1,896,000 | +1.6% | 65,300 | -1.4% | 0.00% | -25.0% |
| Q3 2020 | $1,867,000 | -16.8% | 66,200 | -4.6% | 0.00% | -20.0% |
| Q2 2020 | $2,244,000 | -22.9% | 69,400 | -2.9% | 0.01% | -28.6% |
| Q1 2020 | $2,912,000 | -34.3% | 71,500 | -0.6% | 0.01% | 0.0% |
| Q4 2019 | $4,434,000 | -36.1% | 71,900 | -24.5% | 0.01% | -36.4% |
| Q3 2019 | $6,938,000 | -26.0% | 95,200 | -16.5% | 0.01% | -26.7% |
| Q2 2019 | $9,370,000 | +62.4% | 114,000 | +39.4% | 0.02% | +66.7% |
| Q1 2019 | $5,769,000 | +100.6% | 81,785 | +28.0% | 0.01% | +80.0% |
| Q4 2018 | $2,876,000 | -82.8% | 63,900 | -78.3% | 0.01% | -80.0% |
| Q3 2018 | $16,673,000 | -16.9% | 294,900 | -1.8% | 0.02% | -19.4% |
| Q2 2018 | $20,066,000 | +12.7% | 300,400 | -1.8% | 0.03% | +10.7% |
| Q1 2018 | $17,803,000 | +996.2% | 305,800 | +1113.5% | 0.03% | +833.3% |
| Q4 2017 | $1,624,000 | +27.4% | 25,200 | +3.7% | 0.00% | +50.0% |
| Q3 2017 | $1,275,000 | +12.1% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,137,000 | -5.5% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,203,000 | -24.2% | 24,300 | -7.3% | 0.00% | -33.3% |
| Q4 2016 | $1,588,000 | +50.7% | 26,200 | +64.8% | 0.00% | +50.0% |
| Q3 2016 | $1,054,000 | +18.8% | 15,900 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $887,000 | +62.8% | 15,900 | -1.9% | 0.00% | +100.0% |
| Q1 2016 | $545,000 | -28.1% | 16,200 | -3.6% | 0.00% | -50.0% |
| Q4 2015 | $758,000 | +88.1% | 16,800 | +64.7% | 0.00% | +100.0% |
| Q3 2015 | $403,000 | -36.2% | 10,200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $632,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |